FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Langley LaTanya		 2. Issuer Name and Ticker or Trading Symbol

EDGEWELL PERSONAL CARE Co [ EPC ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Legal Officer
(Last)          (First)          (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY, 6 RESEARCH DRIVE		 3. Date of Earliest Transaction (MM/DD/YYYY)

4/1/2022
(Street)

SHELTON, CT 06484
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Options 4/1/2022 $36.77 4/1/2022  A   5031    11/12/2022 (1)4/1/2032 Common Stock 5031 $0.00 5031 D  
Restricted Stock Equivalents 4/1/2022 $0.00 4/1/2022  A   2652    11/12/2022 (2) (2)Common Stock 2652 $0.00 2652 D  
Restricted Stock Equivalents 4-1-2022 $0.00 4/1/2022  A   9519    4/1/2023 (3) (3)Common Stock 9519 $0.00 9519 D  
Performance Restricted Stock Equivalents 4/1/2022 $0.00 4/1/2022  A   8839    11/12/2024 (4) (4)Common Stock 8839 $0.00 8839 D  
Explanation of Responses:
(1) One-third of the Options will become exercisable on each of 11/12/2022, 11/12/2023 and 11/12/2024, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
(2) One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/12/2022, 11/12/2023 and 11/12/2024 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
(3) One-half of the RSEs will vest and convert into shares of Edgewell common stock on each of 4/1/2023 and 4/1/2024 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.
(4) The PRSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2024 if the following specified performance criteria is met: Relative Total Shareholder Return for the "Performance Period" beginning on October 1, 2021 and ending on September 30, 2024 (100%). Percentage will range from 0% to 100% based on company performance. The amount shown is the maximum amount available to vest.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Langley LaTanya
C/O EDGEWELL PERSONAL CARE COMPANY
6 RESEARCH DRIVE
SHELTON, CT 06484

Chief Legal Officer
Signatures
LaTanya Langley4/1/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Edgewell Personal Care (NYSE:EPC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Edgewell Personal Care Charts.
Edgewell Personal Care (NYSE:EPC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Edgewell Personal Care Charts.